314 related articles for article (PubMed ID: 26646449)
1. SIRT1 inhibition impairs non-homologous end joining DNA damage repair by increasing Ku70 acetylation in chronic myeloid leukemia cells.
Zhang W; Wu H; Yang M; Ye S; Li L; Zhang H; Hu J; Wang X; Xu J; Liang A
Oncotarget; 2016 Mar; 7(12):13538-50. PubMed ID: 26646449
[TBL] [Abstract][Full Text] [Related]
2. SIRT1 downregulation enhances chemosensitivity and survival of adult T-cell leukemia-lymphoma cells by reducing DNA double-strand repair.
Li L; Ye S; Yang M; Yu W; Fan Z; Zhang H; Hu J; Liang A; Zhang W
Oncol Rep; 2015 Dec; 34(6):2935-42. PubMed ID: 26398583
[TBL] [Abstract][Full Text] [Related]
3. KU70 Inhibition Impairs Both Non-Homologous End Joining and Homologous Recombination DNA Damage Repair Through SHP-1 Induced Dephosphorylation of SIRT1 in T-Cell Acute Lymphoblastic Leukemia (T-ALL) [corrected].
Yu W; Li L; Wang G; Zhang W; Xu J; Liang A
Cell Physiol Biochem; 2018; 49(6):2111-2123. PubMed ID: 30273928
[TBL] [Abstract][Full Text] [Related]
4. SIRT1 and LSD1 competitively regulate KU70 functions in DNA repair and mutation acquisition in cancer cells.
Roth M; Wang Z; Chen WY
Oncotarget; 2016 Aug; 7(31):50195-50214. PubMed ID: 27384990
[TBL] [Abstract][Full Text] [Related]
5. Divalproex sodium enhances the anti-leukemic effects of imatinib in chronic myeloid leukemia cells partly through SIRT1.
Wang W; Zhang J; Li Y; Yang X; He Y; Li T; Ren F; Zhang J; Lin R
Cancer Lett; 2015 Jan; 356(2 Pt B):791-9. PubMed ID: 25449787
[TBL] [Abstract][Full Text] [Related]
6. Nicotinamide increases the sensitivity of chronic myeloid leukemia cells to doxorubicin via the inhibition of SIRT1.
Pan S; Leng J; Deng X; Ruan H; Zhou L; Jamal M; Xiao R; Xiong J; Yin Q; Wu Y; Wang M; Yuan W; Shao L; Zhang Q
J Cell Biochem; 2020 Jan; 121(1):574-586. PubMed ID: 31407410
[TBL] [Abstract][Full Text] [Related]
7. UBE2S, a novel substrate of Akt1, associates with Ku70 and regulates DNA repair and glioblastoma multiforme resistance to chemotherapy.
Hu L; Li X; Liu Q; Xu J; Ge H; Wang Z; Wang H; Wang Z; Shi C; Xu X; Huang J; Lin Z; Pieper RO; Weng C
Oncogene; 2017 Feb; 36(8):1145-1156. PubMed ID: 27593939
[TBL] [Abstract][Full Text] [Related]
8. Checkpoint kinase‑1 inhibition and etoposide exhibit a strong synergistic anticancer effect on chronic myeloid leukemia cell line K562 by impairing homologous recombination DNA damage repair.
Fan Z; Luo H; Zhou J; Wang F; Zhang W; Wang J; Li S; Lai Q; Xu Y; Wang G; Liang A; Xu J
Oncol Rep; 2020 Nov; 44(5):2152-2164. PubMed ID: 32901871
[TBL] [Abstract][Full Text] [Related]
9. Ku70 acetylation and modulation of c-Myc/ATF4/CHOP signaling axis by SIRT1 inhibition lead to sensitization of HepG2 cells to TRAIL through induction of DR5 and down-regulation of c-FLIP.
Kim MJ; Hong KS; Kim HB; Lee SH; Bae JH; Kim DW; Dao TT; Oh WK; Kang CD; Kim SH
Int J Biochem Cell Biol; 2013 Mar; 45(3):711-23. PubMed ID: 23247197
[TBL] [Abstract][Full Text] [Related]
10. Reactivation of p53 by novel MDM2 inhibitors: implications for pancreatic cancer therapy.
Azmi AS; Philip PA; Aboukameel A; Wang Z; Banerjee S; Zafar SF; Goustin AS; Almhanna K; Yang D; Sarkar FH; Mohammad RM
Curr Cancer Drug Targets; 2010 May; 10(3):319-31. PubMed ID: 20370686
[TBL] [Abstract][Full Text] [Related]
11. SIRT1 promotes DNA repair activity and deacetylation of Ku70.
Jeong J; Juhn K; Lee H; Kim SH; Min BH; Lee KM; Cho MH; Park GH; Lee KH
Exp Mol Med; 2007 Feb; 39(1):8-13. PubMed ID: 17334224
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide RNAi Screening Identifies RFC4 as a Factor That Mediates Radioresistance in Colorectal Cancer by Facilitating Nonhomologous End Joining Repair.
Wang XC; Yue X; Zhang RX; Liu TY; Pan ZZ; Yang MJ; Lu ZH; Wang ZY; Peng JH; Le LY; Wang GY; Peng QH; Meng Y; Huang W; Liu RY
Clin Cancer Res; 2019 Jul; 25(14):4567-4579. PubMed ID: 30979744
[TBL] [Abstract][Full Text] [Related]
14. Ku70 and Rad51 vary in their importance for the repair of doxorubicin- versus etoposide-induced DNA damage.
Schonn I; Hennesen J; Dartsch DC
Apoptosis; 2011 Apr; 16(4):359-69. PubMed ID: 21107697
[TBL] [Abstract][Full Text] [Related]
15. E1A overcomes the apoptosis block in BCR-ABL+ leukemia cells and renders cells susceptible to induction of apoptosis by chemotherapeutic agents.
Stiewe T; Parssanedjad K; Esche H; Opalka B; Pützer BM
Cancer Res; 2000 Jul; 60(14):3957-64. PubMed ID: 10919674
[TBL] [Abstract][Full Text] [Related]
16. A new phosphorylated form of Ku70 identified in resistant leukemic cells confers fast but unfaithful DNA repair in cancer cell lines.
Bouley J; Saad L; Grall R; Schellenbauer A; Biard D; Paget V; Morel-Altmeyer S; Guipaud O; Chambon C; Salles B; Maloum K; Merle-Béral H; Chevillard S; Delic J
Oncotarget; 2015 Sep; 6(29):27980-8000. PubMed ID: 26337656
[TBL] [Abstract][Full Text] [Related]
17. Imatinib mesylate (STI571) abrogates the resistance to doxorubicin in human K562 chronic myeloid leukemia cells by inhibition of BCR/ABL kinase-mediated DNA repair.
Majsterek I; Sliwinski T; Poplawski T; Pytel D; Kowalski M; Slupianek A; Skorski T; Blasiak J
Mutat Res; 2006 Jan; 603(1):74-82. PubMed ID: 16388976
[TBL] [Abstract][Full Text] [Related]
18. High levels of SIRT1 expression enhance tumorigenesis and associate with a poor prognosis of colorectal carcinoma patients.
Chen X; Sun K; Jiao S; Cai N; Zhao X; Zou H; Xie Y; Wang Z; Zhong M; Wei L
Sci Rep; 2014 Dec; 4():7481. PubMed ID: 25500546
[TBL] [Abstract][Full Text] [Related]
19. Synthetic lethality of combined AT-101 with idarubicin in acute myeloid leukemia via blockade of DNA repair and activation of intrinsic apoptotic pathway.
Yang Q; Chen K; Zhang L; Feng L; Fu G; Jiang S; Bi S; Lin C; Zhou Y; Zhao H; Chen XL; Fu G; Xu B
Cancer Lett; 2019 Oct; 461():31-43. PubMed ID: 31301319
[TBL] [Abstract][Full Text] [Related]
20. Myeloid leukemias have increased activity of the nonhomologous end-joining pathway and concomitant DNA misrepair that is dependent on the Ku70/86 heterodimer.
Gaymes TJ; Mufti GJ; Rassool FV
Cancer Res; 2002 May; 62(10):2791-7. PubMed ID: 12019155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
